View Older Stories View More Recent Stories
-
Roth Capital Says MeetMe's (MEET) Weakness is Related to Selling From Large Legacy Shareholder - Reiterates Buy
-
Streetinsider.com's Hot Lunchtime Reads 1/13: (ESRX) (MSFT) (AAPL) (LGND)
-
Roth Capital Impressed by Speed of Ligand (LGND) Capitalizing on OMT Acquisition; Affirms at 'Buy'
-
PlacementTracker Publishes 2015 PIPE Market League Tables
-
Roth Positive on BioLineRx (BLRX) and Merck's BL-8040 + KEYTRUDA Collaboration
-
Roth Capital Cuts PT Due to Natus Medical's (BABY) Light 2016 Outlook Following Venezuela Contract Delay
-
Roth Capital Slashes PT on Skullcandy (SKUL) to $5.50; Move to Wireless Could Still Pressure Shares
-
Low Production at Rochester Offset Results for Coeur Mining's (CDE) 4Q - Roth Capital Cuts PT to $6
-
Eilers Research Announces Name Change to “Eilers & Krejcik Gaming, LLC”
-
Highpower Special Committee Engages Financial Advisor and Legal Counsel
-
Roth Capital Cuts Price Target on Synergy Resources (SYRG) to $13 Following 1Q Results
-
Roth Capital Still Values Flamel Technologies (FLML) Following Revisions - Cuts PT to $17.50
-
Low Membership Income Hurts PriceSmart's (PSMT) 1Q - Roth Capital Cuts PT to $85
-
Galena Biopharma (GALE) Prices 19.8M Common Stock and Warrant Offering at $1.10/Unit
-
Galena Biopharma Announces Pricing of Public Offering of Common Stock and Warrants
-
Roth Slashes PT on TetraLogic (TLOG) to $1 as Two Studies Show Negative Results
-
Roth Capital Weighs in on uniQure (QURE) After First Human Positive Hemophilia B Data
-
Roth Capital Raises Price Target on MeetMe (MEET) Following Pre-Announced Upside
-
Roth Capital Reiterates Buy Following Conatus Pharmaceuticals (CNAT) Phase II Emricasan Data
-
Roth Capital Remains Bullish as Flex Pharma (FLKS) Completes NLC Enrollment
-
General Employment (JOB) Ends Year with 4th Acquisition of 2015 - Roth Capital Reiterates Buy
-
Roth Capital Starts Intevac (IVAC) at Buy, $8.50 PT
-
A Positive Pre-Announcement Keeps Roth Capital Bullish on GigOptix (GIG) - PT to $5
-
Roth Capital Remains Bullish as Channel Checks Suggest 4Q Rental Strength for Outerwall (OUTR)
-
Roth Capital Starts Planet Fitness (PLNT) at Buy
-
Unusual 11 Mid-Day Movers 12/31: (LEI) (TLOG) (PSTI) Higher; (INVT) (FLML) (OHGI) Lower
-
Roth Capital Maintains Buy on Flamel (FLML) Despite Earlier-Than-Expected Bloxiverz Competition
-
Notable Analyst Rating Changes 12/31: (OKE) Upgraded; (HPY) Downgraded
-
Roth Capital Remains Bullish Following Ligand Pharma's (LGND) Supply Agreement with Gilead (GILD)
-
Pre-Open Stock Movers 12/31: (PSTI) (PBMD) (ANFI) Higher; (AVXL) (AEZS) Lower (more...)
-
Lucas Energy (LEI) to Acquire Producing Properties and Undeveloped Acreage; Includes Mid-Continent Region
-
Lucas Energy Announces Entry Into Mid-Continent With Agreement To Acquire Hunton Properties
-
Prima BioMed Ltd (PBMD) Gains as Analyst Sees Over 400% Upside
-
After-Hours Stock Movers 12/30: (PBMD) (CMRX) Higher; (AEZS) Lower (more...)
-
Roth Capital Starts Prima Biomed (PBMD) at Buy; $6 PT
-
Roth Capital Starts Tetralogic Pharmaceuticals (TLOG) at Buy; $5 PT
-
Lilis Energy to Merge With Brushy Resources
-
Hemostemix Joins the OTCQX Marketplace in the United States
-
OTC Markets Group Welcomes Hemostemix to OTCQX
-
Aduro Biotech (ADRO) Added to Focus List at Roth Capital
-
Iradimed Corp. (IRMD) Closes $29.1M Secondary Offering of Common Stock
-
IRADIMED CORPORATION Announces Closing of $29.1 Million Secondary Offering of Common Stock and Exercise of Overallotment Option
-
Notable Analyst Rating Changes 12/22: (SAVE) (FINL) (BAH) Upgraded; (CMG) (SCSS) (PHM) Downgraded
-
Roth Capital Starts Fenix Parts (FENX) at Buy
-
Roth Capital Reiterates Buy Following Neogen Corp's (NEOG) Mixed 2Q Results
-
Roth Capital Starts Fibrocell Science (FCSC) at Buy
-
Roth Capital Starts Etsy (ETSY) at Sell
-
Roth Capital Starts Marchex (MCHX) at Buy
-
Sorl Auto Parts (SORL) Forms Special Committee to Evaluate 'Go Private' Offer
-
SORL Auto Parts Announces Formation of a Special Committee to Evaluate Non-Binding Proposal

